Skip to main content
Caplight Logo









Medlinker

Medlinker

Private
ChengduHealthcare & Life Scienceshttps://www.medlinker.com/index

Last Round

Series E

Dec 30, 2020

Est. Valuation

$3.93B

Total Funding Raised

$1.43B

Company Overview

Medlinker is a healthcare technology company that operates an AI-driven medical platform providing chronic disease management, expert doctor consultations, and digital health services.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, EHR & EMR

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

telemedicinedigital healthcarechronic disease managementonline-to-offlineO2Omedical practice managementclinical collaborationmedical AIMedGPThealthtechtelehealth platformclinical decision supportpatient managementvertical SaaSAI triage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medlinker Comparables

Compare Medlinker with similar companies based on industry and business-model similarity.

Medlinker comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing Yuanxin Technology Group Co., Ltd.
84%
Ping An Healthcare and Technology Company Limited
84%
WeDoctor
83%

Medlinker Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EDec 30, 2020
Series EDec 1, 2020
Series DJul 31, 2018
Series DJun 1, 2018
Series CDec 6, 2017
Series B
Sep 7, 2015

Key People

Founding team and executive leadership

周正

COO

Executive Team

Medlinker Investors

Notable investors and investment history

Medlinker investors
InvestorRounds
PreAngelAngel
Ceyuan VenturesSeries A, Angel
Agricultural Bank of China InternationalSeries D
CCIC CapitalSeries D
招银国际金融有限公司Series B
Huasheng CapitalSeries C, Series B, Series D
China Investment CorporationSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 31, 2018

    $147M round led by China Investment Corporation

  • Jun 1, 2018

    $147M round led by CCIC Capital

Medlinker Filings

Explore SEC and related filing metadata, where available.

Medlinker filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medlinker's valuation, stock price, and market status.

Is Medlinker a public or private company?

Medlinker is a private company.

What is the current stock price of Medlinker?

Medlinker is a private company with no public stock price. No recent secondary market data is available.

How much is Medlinker worth (valuation)?

Medlinker's valuation is estimated at $3.9B based on funding round data.

Can I buy Medlinker stock?

Medlinker shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medlinker's last funding round?

Medlinker's most recent funding round was Series E on December 30, 2020.

Who are the main investors in Medlinker?

Key investors in Medlinker include HongShan.

Will Medlinker IPO soon?

No public IPO plans have been announced for Medlinker.

How can I track Medlinker secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medlinker's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChengdu
Employee Range195
Year Founded2014
Last FundingDec 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?